Atip – Avenir Program

Every year, as part of a partnership, Inserm and the French National Center for Scientific Research (CNRS) launch a call for proposals aimed at enabling young researchers to create and lead a team within an established Inserm or CNRS research center. The teams formed will work to strengthen the research of the host unit by independently developing their own research projects. This program aims to promote mobility and attract young, high-caliber team leaders.

Atip-Avenir 2021

Opening of the registrations online: 15 octobre 2020

Deadline for the online submission: 18 novembre 2020

More informations on Eva

Who can apply?

The ATIP - Avenir program is open to young researchers of any nationality, who have successfully defended their Ph.D. thesis (or equivalent degree) in the last 2 to 8 years. Exceptions can be granted for maternity (1 year per child), paternity or military leave.

The program is open to all young researchers, irrespective of their current position (Public Scientific and Technical Research Establishment (EPST), university, hospital, veterinary school, etc.) and to any non-tenured researcher.

Applications from Doctors of Medicine/Pharmacy and women are strongly encouraged.

Recipients of financial support for young researchers similar to the ATIP-Avenir program are not eligible (e.g. ANR or ERC funding to develop an independent project). Applicants must not have been working for their host laboratory for more than 18 months and may not work with any of their previous mentors. Exceptions can be granted to applicants from university hospitals. Applicants may submit their proposal without an identified host laboratory.

Applicants may not apply to more than 2 different calls for proposals.

The projects put forward must relate to Life Sciences or Health. Interdisciplinary projects combining biology and mathematics, physical sciences, informatics, chemistry, public health (more specifically social determinants of health and/or healthcare services) are encouraged. Projects should comply with the ethical rules of Inserm and CNRS.

What funding is allocated?

The funding allocated includes at least:

  • an annual grant of €60,000
  • a two-year fixed-term contract for a postdoctoral researcher
  • a three-year salary for non-tenured successful applicants

The host laboratory will provide the team with a dedicated research area of at least 50 m², (infrastructure fees will be paid by the host laboratory), and ensure access to the technological platforms on the site.

The ATIP – Avenir grant is allocated for a period of 3 years. It can be extended for an additional 2 years.

Some partners may co-fund projects in their fields : ANRS (Agence nationale de recherches sur le sida et les hépatites virales), AFM (Association française contre les myopathies), ARC (Fondation ARC pour la recherche sur le cancer), FINOVI (Fondation innovations en infectiologie), Fondation Bettencourt Schueller, LNCC (Ligue nationale contre le cancer), Plan Cancer, universités.

How are applicants selected?

There is a two-stage selection process: shortlisting (generally in April), followed by interviews of the selected applicants (generally mid-June). The final list of applicants is established jointly between Inserm and CNRS and generally published early July.

Applications are assessed by an international scientific committee made up of relevant experts:

  • LS1: Molecular and Structural Biology, and Biochemistry
  • LS2: Genetics, Genomics, Bioinformatics and Systems Biology
  • LS3: Cell Biology, Development and Evolution
  • LS4: Physiology, Physiopathology and Translational Research
  • LS5: Neurosciences and Disorders of the Nervous System
  • LS6:  Immunity, Infection and Microbiology
  • LS7: Diagnostic tools, Therapies, Biotechnology and Public Health

Evaluation Committee Composition

Additional information and details

Inserm : Christiane Durieux (
CNRS : Catherine Cavard (